J A van Mourik
Overview
Explore the profile of J A van Mourik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
2131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bierings R, van den Biggelaar M, Kragt A, Mertens K, Voorberg J, van Mourik J
J Thromb Haemost
. 2007 Sep;
5(12):2512-9.
PMID: 17883593
Background: After de novo synthesis in endothelial cells, the chemokine interleukin-8 (IL-8) is targeted to endothelial cell-specific storage vesicles, the Weibel-Palade bodies (WPBs), where it colocalizes with von Willebrand factor...
2.
Kremer Hovinga J, Zeerleder S, Kessler P, Romani de Wit T, van Mourik J, Hack C, et al.
J Thromb Haemost
. 2007 Sep;
5(11):2284-90.
PMID: 17764538
Background: Insufficient control of von Willebrand factor (VWF) multimer size as a result of severely deficient ADAMTS-13 activity results in thrombotic thrombocytopenic purpura associated with microvascluar thrombosis and platelet consumption,...
3.
Coppens M, van Mourik J, Eckmann C, Buller H, Middeldorp S
J Thromb Haemost
. 2007 Aug;
5(9):1979-81.
PMID: 17723140
No abstract available.
4.
Eckmann C, De Laaf R, Van Keulen J, van Mourik J, de Laat B
J Thromb Haemost
. 2007 Jun;
5(6):1330-1.
PMID: 17567447
No abstract available.
5.
Nossent A, van Marion V, VAN Tilburg N, Rosendaal F, Bertina R, van Mourik J, et al.
J Thromb Haemost
. 2006 Oct;
4(12):2556-62.
PMID: 17059421
Background And Objectives: Elevated levels of factor (F)VIII are associated with an increased risk of thrombosis. FVIII levels are determined mainly by von Willebrand factor (VWF). We have investigated the...
6.
Luken B, Kaijen P, Turenhout E, Kremer Hovinga J, van Mourik J, Fijnheer R, et al.
J Thromb Haemost
. 2006 Aug;
4(11):2355-64.
PMID: 16898953
Background: The cysteine-rich/spacer domains of ADAMTS13 contain a major binding site for antibodies in patients with acquired thrombotic thrombocytopenic purpura (TTP). Objective: To study the heterogeneity of the antibody response...
7.
Bouma B, van Mourik J
J Thromb Haemost
. 2006 Feb;
4(3):489-95.
PMID: 16460427
No abstract available.
8.
Frijns C, Fijnheer R, Algra A, van Mourik J, van Gijn J, Rinkel G
J Neurol Neurosurg Psychiatry
. 2005 Dec;
77(1):77-83.
PMID: 16361599
Objective: To investigate the relation of endothelial cell activation with delayed cerebral ischaemia (DCI) and outcome after subarachnoid haemorrhage (SAH). Methods: Concentrations of soluble (s) intercellular adhesion molecule-1, sE-selectin, sP-selectin,...
9.
Brinkman H, Mertens K, van Mourik J
J Thromb Haemost
. 2005 Dec;
3(12):2712-20.
PMID: 16359509
Background: Protein S is a vitamin K-dependent protein with anticoagulant properties. It contains a so-called thrombin-sensitive region (TSR), which is susceptible to cleavage by coagulation factor Xa (FXa) and thrombin....
10.
Romani de Wit T, Rondaij M, van Mourik J
Ned Tijdschr Geneeskd
. 2004 Sep;
148(32):1572-7.
PMID: 15382555
Vascular endothelial cells contain typical elongated vesicles, known as Weibel-Palade bodies. These organelles serve as a storage compartment for a variety of proteins that play a part in controlling vascular...